模板跳转编辑方法在F9-相关血友病B基因治疗中
Robert Sattarov1, Alexey Kuznetsov1, Valeriy Klimko1
1Translational Medicine Research Center, Sirius University of Science and Technology, 1 Olympic Ave., Federal Territory Sirius, 354340 Sirius, Russia.
International journal of molecular sciences
|December 30, 2025
概括
这项研究引入了B型血友病的首要编辑,B型血友病是一种遗传性血液疾病. 这种新的CRISPR/Cas基因治疗方法旨在通过非病毒传递来纠正F9基因突变,以改善治疗.
科学领域:
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
- 基因治疗 基因治疗
背景情况:
- 血友性B是一种遗传性出血疾病,由F9基因突变引起.
- 目前的治疗方法,如因子IX (FIX) 输液,具有局限性,包括抑制剂的发展和持续的出血.
- 需要先进的基因疗法来治疗B型血友病.
研究的目的:
- 评估一种用于在B型血友病中F9基因校正的新原始编辑策略.
- 探索CRISPR/Cas基因治疗的非病毒传递系统.
- 为了解决现有的基于AAV的基因疗法的局限性.
主要方法:
- 利用CRISPR/Cas原始编辑来准特定的F9基因区域.
- 专注于编码氨基酸的突变 374 V 到 408 Q.
- 为基因编辑应用研究的非病毒传递.
主要成果:
- 主编辑方法证明了纠正致病F9突变的潜力.
- 该方法准了B型血友病患者突变的很大一部分.
- 该策略允许从临床前阶段到临床阶段的无过渡,而无需修改序列.
结论:
- 总编辑为血友病B基因治疗提供了一个有希望的新途径.
- 这种方法可以克服与当前治疗方法和AAV载体相关的局限性.
- 进一步的研究是有必要的,以优化主要编辑体内应用和治疗疗效.
相关概念视频
CRISPR
57.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.3K
Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
Conservative Site-specific Recombination and Phase Variation
6.6K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.6K
Long-patch Base Excision Repair
7.8K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.8K


